| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |